|
|
Government probes potential risks of cancer, flu, MS drugs
WASHINGTON (Reuters) - U.S. health regulators are reviewing potential risks of medicines from Roche Holding AG, Novartis AG and other companies.
Source:(Reuters)
2010-02-17
Gene discovery may help guide breast cancer care
CHICAGO (Reuters) - An abnormality in two genes can make a common class of chemotherapy drugs used to fight breast cancer less effective, U.S. researchers said on Sunday in a finding that could help doctors better tailor treatments.
Nations:U.S. Source:(Reuters)
2010-01-24
Amgen: Strengthening Bones, Weakening Cancer?
When Amgen (NasdaqGS:AMGN - News) put its new treatment for the bone-thinning disease osteoporosis up for review by the Food & Drug Administration last year, it got an unwelcome rebuke. On Oct. 19 the agency came back with a request for more information on how the company plans to manage infection risks associated with the medicine.
Source:(BusinessWeek)
2010-01-15
In colon cancer drug study, more wasn't better
NEW YORK - Doctors thought that combining two newer drugs that more precisely attack cancer would help people with advanced colon cancer. Instead, it made the cancer worse and made the patients more miserable, a study found. The surprising findings underscore the importance of doing rigorous studies before rushing to mix these pricey, new-generation drugs, the Dutch researchers and other experts said.
Nations:Netherlands Source:(AP)
2009-02-04
FDA pledges openness on gene-altered products
WASHINGTON - Federal health officials Thursday pledged a new, open process for approving drugs and foods from genetically engineered animals.
Source:(AP)
2009-01-16
| Headlines |
|
Matches Shown: | 1-50 | 51-100
|
|
|
Gene Chip
